2m 2m 2m 2m 2m 2m 2m
PALVELLA THERA (PVLA)
NASDAQ
$150.26+$0.13 (+0.08%)
Price as of Sep 11, 2026 7:30 PM EDT- $2.2BMarket Cap
- 164.13%1-Year Change
- BiotechnologyIndustry
PALVELLA THERA (PVLA)
$150.26+$0.13 (+0.08%)
PVLA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $150.13 | ||
Change | -$0.26 (-0.17%) | ||
Open | $152.75 | ||
High | $154.30 | ||
Low | $149.98 | ||
Previous Close | $150.39 | ||
Volume | 163,366 | ||
30-Day Average Volume | 191,537 | ||
1-Week Change | -4.52% | ||
1-Month Change | -2.70% | ||
1-Year Change | 164.13% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 14.4M | ||
Total Assets | $253.5M | ||
Market Cap | $2.2B | ||
Enterprise Value | $2.0B | ||
Period: QTR TTM FY | |||
Revenue | $1.9M | ||
Net Income | -$21.9M | ||
Free Cash Flow | -$12.8M | ||
EBIT | -$21.9M | ||
EBITDA | -$21.9M | ||
Net Working Capital | $241.1M | ||
EPS | -$1.52 | ||
Enterprise Value/EBITDA | -90 | ||
Enterprise Value/Revenue | 1,021 | ||
P/B | 10 | ||
P/E | -99 | ||
PEG | 4 | ||
Price/Free Cash Flow | -168 | ||
Price/Operating Cash Flow | -168 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue